An oft-repeated message is that primary aldosteronism is not rare; it is quite common. An equally urgent message is that primary aldosteronism, when left untreated, is extremely dangerous. Strong ...
Corticosteroid signaling by glucocorticoids is mediated through two distinct intracellular receptor subtypes referred as the mineralocorticoid ... in ligand-independent pathways that regulate ...
Finerenone is a non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA) and the first drug targeting the mineralocorticoid receptor (MR) pathway that has demonstrated cardiovascular ...